4516.T
Nippon Shinyaku Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 3,499.00
+0.06%Year over year
Reported trailing growth
- Revenue
- +5.9%
- EBITDA
- —
- EBIT
- -1.6%
- EPS
- -1.8%
- Free cash flow
- +40.8%
- Operating cash flow
- +22.6%
Forward estimates
Based on analyst estimates
- Revenue
- +2.4%
- EBITDA
- —
- EPS
- -11.9%
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- +3.4%
- EBIT
- +2.5%
- Net income
- +9.2%
- EPS
- +9.2%
- Free cash flow
- +21.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026